Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Grape seed extract is a standardized botanical extract derived from the seeds of Vitis vinifera (grape), notable for its high content of oligomeric proanthocyanidins (OPCs) and related polyphenols such as catechins, gallic acid, and other flavonoids[1][2][3][4][5]. It is widely used as a dietary supplement for its potent antioxidant and anti-inflammatory properties, being 15–50 times more effective than vitamin E and C in some assays. Grape seed extract is promoted for cardiovascular health, cancer prevention (in vitro only), anti-aging effects, and claims related to eye health and skin protection, though large-scale human evidence remains limited and heterogenous[1][2][4][5]. It is not a single chemical entity, nor a protein-based molecular target, and should not be classified as a therapeutic target for drug development in the traditional sense.
Antioxidant (scavenging reactive oxygen species); Inhibits lipid peroxidation; Modulates inflammatory mediators (histamine, prostaglandins, leukotrienes); Inhibits fat-metabolizing enzymes (pancreatic lipase, lipoprotein lipase); Potential apoptosis induction (in vitro, cancer cells)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Grape seed extract (GSE).